Section divider

Since 2004, we’ve reached millions of Mozambicans with quality health services.

  • More than 2.9 million Mozambicans learned their HIV status through Jhpiego-led initiatives, and over 1.5 million men received voluntary medical male circumcision services for HIV prevention.
  • At Jhpiego-supported health care facilities, over 1.5 million pregnant women attended antenatal care visits with skilled providers, and more than 1.9 million babies were delivered with a skilled attendant.
  • Thanks to Jhpiego-supported services, more than 441,000 women were screened for cervical cancer using visual inspection with acetic acid.
  • More than 300,000 people were reached by a Jhpiego-supported intervention against gender-based violence.

Our Work in Mozambique

With funding from the U.S. Agency for International Development (USAID), RISE is working in select countries, including Mozambique, to address the COVID-19 pandemic. In line with ministry of health priorities in each country, RISE’s COVID-19 response support may include: assisting in the planning and rollout of national vaccine plans, including ensuring health care workers are prepared to implement and monitor this plan; providing focused and clinically relevant capacity building for clinicians providing COVID-19 case management; strengthening the oxygen ecosystem; and supporting health care workers in oxygen conservation, rationalization and non-invasive respiratory care.

RISE is a five-year global project—funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and USAID—that works with countries to achieve a shared vision of attaining and maintaining epidemic control, with stronger local partners capable of managing and achieving results through sustainable, self-reliant and resilient health systems. The project is led by Jhpiego with the following partners: ICAP at Columbia University, Management Sciences for Health, Anova, BAO Systems, Johns Hopkins University Center for Public Health and Human Rights, and Mann Global Health. For the COVID-19 ventilator technical assistance effort, RISE is also collaborating with the University of California San Francisco, World Federation of Societies of Anesthesiologists (via the GH STAR project), FHI 360 (via the EpiC Project) and Johns Hopkins University emergency medicine and critical care staff.

This six-year project, funded by the U.S. Centers for Disease Control and Prevention (CDC), supports the Mozambican Ministry of Health (MOH) to strengthen the health care system and deliver evidence-based interventions to achieve the goal of an AIDS-free generation in Mozambique, as outlined in the MOH’s HIV and AIDS Response Strategic Acceleration Plan. Jhpiego implements this national project in coordination with the Government of Mozambique and key implementing partners, including two local nongovernmental organizations. Jhpiego is strengthening the capacity of the Mozambican MOH to expand quality services in the following technical areas: voluntary medical male circumcision, HIV counseling and testing, gender-based violence, TB infection control, and occupational health and workplace safety for health care workers. Additionally, Jhpiego collaborates with the MOH to strengthen the health system via health information systems, human resources for health planning and deployment, and continuing education.

Under this project, funded by the U.S. Department of Defense, Jhpiego is working with the Mozambican defense force (known as Forças Armadas de Defesa de Moçambique, or FADM) to strengthen and scale up a comprehensive HIV prevention, care and treatment program. The project goal is to reduce the number of new HIV infections and other sexually transmitted infections among FADM members, their families and the civilian communities served by FADM. Jhpiego is working with FADM to: 1) maintain and expand antiretroviral therapy for HIV/AIDS care and treatment; 2) scale up HIV/AIDS testing services; 3) integrate care for HIV and TB at target sites; 4) initiate pregnant or breastfeeding women on lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV; 5) ensure that FADM clinical laboratories have adequate equipment/supplies to provide HIV and TB laboratory services; and 6) support HIV clinical monitoring systems.

This project, funded by the U.S. Department of Defense, seeks to reduce new HIV infections and other sexually transmitted infections among members of the Mozambican defense force (known as Forças Armadas de Defesa de Moçambique, or FADM), their families and the civilian communities served by FADM. Jhpiego is working to achieve this goal by supporting FADM to: 1) perform voluntary medical male circumcisions for the military population and civilians; 2) provide HIV testing services to military and civilians and link those who test positive for HIV with care and treatment services; and 3) implement non-clinical HIV prevention activities.

Under this project funded by the U.S. Department of Defense, Jhpiego is working directly with the Mozambican defense force (known as Forças Armadas de Defesa de Moçambique, or FADM) to conduct a multi-year study. This study is evaluating the impact of implementing the “Treat All” approach for people living with HIV in a military setting, including the impact on the health of military personnel and HIV incidence and transmission in surrounding communities.

Under this Unitaid-funded, five-year grant, Jhpiego is partnering with ISGlobal to reduce maternal and neonatal mortality in the Democratic Republic of Congo, Nigeria, Madagascar and Mozambique by: 1) introducing and setting the stage for scale-up of community intermittent preventive treatment of malaria in pregnancy (IPTp); 2) introducing and increasing demand for quality-assured sulfadoxine-pyrimethamine (SP) for IPTp; and 3) generating evidence for World Health Organization policy change. To achieve desired results, Jhpiego is also collaborating with Medicines for Malaria Venture (to bring quality-assured SP to market) and the World Health Organization (to ensure SP resistance monitoring and foster collaboration between national reproductive health programs and national malaria control programs). For more information, visit here:

With funding from the U.S. Agency for International Development, Jhpiego is implementing a three-year project to establish and scale up VMMC services for men aged 10 to 49 years old in selected sites in Manica and Tete Provinces of Mozambique. These services will ultimately be delivered using an integrated service delivery approach to HIV prevention and treatment via a strengthened local nongovernmental organization that is able to routinely deliver high-quality VMMC services. The overall expected result is for 80% of men aged 15 to 29 years old to obtain high-quality VMMC services in targeted sites, and that increasing numbers of youth and adult men in the target age group are voluntarily coming for the service. To achieve this goal, the project will incorporate a comprehensive VMMC package, including VMMC procedures, HIV testing and counseling, condom promotion, sexually transmitted infection management and undertaking “active” referrals to care and treatment services. The project will also strengthen linkages across HIV service points within facilities, between facilities and between communities and facilities to identify VMMC-eligible men, inform and counsel them and orient them to the closest VMMC service.

The Government of Mozambique awarded Jhpiego a World Bank-funded contract as part of its Integrated Feeder Road Development Project, the objective of which is to rehabilitate and enhance road infrastructure to improve mobility, thereby strengthening livelihoods in local communities. The World Bank and Government of Mozambique recognize that factors related to construction programs (e.g., influx of construction workers, changes in power dynamics, land redistribution) can exacerbate the risk of gender-based violence (GBV), sexual exploitation and abuse, and sexual harassment in both public and private settings. Jhpiego is working in the northern provinces of Mozambique to mitigate these risks and respond to occurrences of sexual violence and abuse by: 1) providing capacity building and assessing the GBV risk and response capacity of the project’s stakeholders; 2) establishing a GBV mitigation action plan and then monitoring the effectiveness of mitigation measures; 3) raising awareness of the obligations of construction workers under the code of conduct within the affected communities; and 4) responding to sexual exploitation/abuse and sexual harassment cases and monitoring their reporting.

GHSC-PSM is led by Chemonics and funded by the U.S. Agency for International Development. In alignment with the program’s procurement of oxygen-related equipment, GHSC-PSM is supporting Jhpiego—in partnership with the Johns Hopkins School of Medicine—to provide clinical technical assistance (TA) for the oxygen ecosystem in five countries (Afghanistan, Ghana, Guatemala, Kenya and Mozambique). The goal of this TA is to build the capacity of clinicians and other staff at selected health facilities to deliver oxygen therapy in the context of clinical case management of newborn, children and adult COVID-19 patients. The generic package of clinical TA includes support for the following: clinical assessment and triage, testing for COVID-19, age-appropriate supplemental oxygen and advanced respiratory care, therapeutic and supportive medical care, infection prevention and control, adaptation of facility information tools, and ongoing mentorship and supportive supervision